United Nations General Assembly. Convention on the Rights of the Child. Annu Rev Popul Law. 1989;16:95, 485–501.

Rodriguez-Wallberg KA, Oktay K. Fertility preservation medicine: options for young adults and children with cancer. J Pediatr Hematol Oncol. 2010;32(5):390–6.

Article  PubMed  Google Scholar 

Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev. 2012;9(Suppl 2):713–7.

PubMed  Google Scholar 

Talaulikar VS, Conway GS, Pimblett A, Davies MC. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome. Fertil Steril. 2019;111(3):505–9.

Article  CAS  PubMed  Google Scholar 

Bernard V, Donadille B, Zenaty D, Courtillot C, Salenave S, Brac de la Perrière A, Albarel F, Fèvre A, Kerlan V, Brue T, Delemer B, Borson-Chazot F, Carel J-C, Chanson P, Léger J, Touraine P, Christin-Maitre S. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod. 2016;31(4):782–788.

McCracken K, Nahata L. Fertility preservation in children and adolescents: current options and considerations. Curr Opin Obstet Gynecol. 2017;29(5):283–8.

Article  PubMed  Google Scholar 

Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, Wallace WH, Wang ET, Loren AW. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994–2001.

Article  PubMed  Google Scholar 

Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000;342(25):1919.

Article  CAS  PubMed  Google Scholar 

Oktay K, Oktem O. Fertility preservation medicine: a new field in the care of young cancer survivors. Pediatr Blood Cancer. 2009;53(2):267–73.

Article  PubMed  Google Scholar 

Poirot C, Brugieres L, Yakouben K, Prades‐Borio M, Marzouk F, Lambert G, Pacquement H, Bernaudin F, Neven B, Paye‐Jaouen A, Pondarre C, Dhedin N, Drouineaud V, Chalas C, Martelli H, Michon J, Minard V, Lezeau H, Doz F, Sarnacki S, Philippe‐Chomette P, Dufour C, Laurence V, Baruchel A, Wolf J, Boissel N, Valteau‐Couanet D, Dalle J. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center. Acta Obstet Gyneco. Scand. 2019;98(5):630–637.

Oktay K, Newton H, Aubard Y, Salha O, G.Gosden R. Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology? Fertil Steril.1998;69(1):1–7.

Sugishita Y, Suzuki N. Methods of ovarian tissue cryopreservation: vitrification. In: Principles and Practice of Ovarian Tissue Cryopreservation and Transplantation. Elsevier; 2022:99–107.

Oktay K, Bedoschi G, Berkowitz K, Bronson R, Kashani B, McGovern P, Pal L, Quinn G, Rubin K. Fertility preservation in women with Turner syndrome: a comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol. 2016;29(5):409–16.

Article  PubMed  Google Scholar 

Oktay K, Bedoschi G. Fertility preservation in girls with Turner syndrome: limitations, current success and future prospects. Fertil Steril. 2019;111(6):1124–6.

Article  PubMed  Google Scholar 

Poirot C. Ovarian cryopreservation for transplantation with prepubertal and adolescent girls. In: Principles and Practice of Ovarian Tissue Cryopreservation and Transplantation. Elsevier; 2022:127–141.

Soleimani R, Heytens E, Oktay K. Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants. Bernhard EJ, ed. PLoS One 2011;6(4):e19475.

Oktay K, Bedoschi G, Pacheco F, Turan V, Emirdar V. First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgery. Am J Obstet Gynecol. 2016;214(1):94.e1-94.e9.

Article  PubMed  Google Scholar 

Taylan E, Oktay K. Application of decellularized tissue scaffolds in ovarian tissue transplantation. In. 2017:177–181.

Taylan E, Oktay K. Autologous transplantation of human ovarian tissue. In: The Ovary. Elsevier; 2019:493–500.

Marin L, Bedoschi G, Kawahara T, Oktay KH. History, evolution and current state of ovarian tissue auto-transplantation with cryopreserved tissue: a successful translational research journey from 1999 to 2020. Reprod Sci. 2020;27(4):955–62.

Article  PubMed  Google Scholar 

Balen A, Harris S, Chambers E, Picton H. Conservation of fertility and oocyte genetics in a young woman with mosaic Turner syndrome. BJOG An Int J Obstet Gynaecol. 2010;117(2):238–42.

Article  CAS  Google Scholar 

Strypstein L, Van Moer E, Nekkebroeck J, Segers I, Tournaye H, Demeestere I, Dolmans M-M, Verpoest W, De Vos M. First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome. J Assist Reprod Genet. 2022;39(2):543–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mature oocyte cryopreservation. a guideline. Fertil Steril. 2013;99(1):37–43.

Article  Google Scholar 

Grèze V, Mechdoud S, Vorilhon S, Isfan F, Rouel N, Chaput L, Brugnon F, Kanold J. Accès à la préservation de la fertilité des adolescents et jeunes adultes de 15 à 24 ans atteints de cancers en Auvergne. France Bull Cancer. 2020;107(7–8):773–8.

Article  PubMed  Google Scholar 

Oktay K, Rodriguez-Wallberg KA, Sahin G. Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure. Fertil Steril. 2010;94(2):753.e15-753.e19.

Article  PubMed  Google Scholar 

Oktay K, Bedoschi G. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in turner syndrome or cancer treatments. J Pediatr Adolesc Gynecol. 2014;27(6):342–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martel RA, Blakemore JK, Fino ME. The use of oocyte cryopreservation for fertility preservation in patients with sex chromosome disorders: a case series describing outcomes. J Assist Reprod Genet. 2022;39(5):1143–53.

Article  PubMed  PubMed Central  Google Scholar 

Mamsen LS, Charkiewicz K, Anderson RA, Telfer EE, McLaughlin M, Kelsey TW, Kristensen SG, Gook DA, Ernst E, Andersen CY. Characterization of follicles in girls and young women with turner syndrome who underwent ovarian tissue cryopreservation. Fertil Steril. 2019;111(6):1217-1225.e3.

Article  PubMed  Google Scholar 

Child TJ, Abdul-Jalil AK, Gulekli B, Tan SL. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril. 2001;76(5):936–42.

Article  CAS  PubMed  Google Scholar 

Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online. 2010;20(5):634–8.

Article  CAS  PubMed  Google Scholar 

Borini A, Coticchio G. Oocyte quantity and quality are crucial for a perspective of fertility preservation in women with Turner syndrome. Fertil Steril. 2019;111(3):461–2.

Article  PubMed  Google Scholar 

Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril. 2018;109(6):993–999.

Cohen Y, St-Onge-St-Hilaire A, Tannus S, Younes G, Dahan MH, Buckett W, Son W-Y. Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes. J Assist Reprod Genet. 2018;35(9):1683–9.

Article  PubMed  PubMed Central  Google Scholar 

Cobo A, Coello A, de los Santos MJ, Giles J, Pellicer A, Remohí J, García-Velasco JA. Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis. Reprod Biomed Online. 2021;42(4):725–732.

Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616–24.

Article  CAS  PubMed  Google Scholar 

The Vienna consensus: report of an expert meeting on the development of art laboratory performance indicators†‡. Hum Reprod Open. 2017;2017(2). https://doi.org/10.1093/hropen/hox011.

Purushothaman R, Lazareva O, Oktay K, Ten S. Markers of ovarian reserve in young girls with Turner’s syndrome. Fertil Steril. 2010;94(4):1557–9.

Article  PubMed  Google Scholar 

Gravholt CH, Viuff M, Just J, Sandahl K, Brun S, van der Velden J, Andersen NH, Skakkebaek A. The changing face of turner syndrome. Endocr Rev. 2023;44(1):33–69.

Article  PubMed  Google Scholar 

Visser JA, Hokken-Koelega ACS, Zandwijken GRJ, Limacher A, Ranke MB, Fluck CE. Anti-Mullerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Hum Reprod. 2013;28(7):1899–907.

Article  CAS  PubMed  Google Scholar 

Vergier J, Bottin P, Saias J, Reynaud R, Guillemain C, Courbiere B. Fertility preservation in Turner syndrome: Karyotype does not predict ovarian response to stimulation. Clin Endocrinol (Oxf). 2019;91(5):646–51.

Article  CAS  PubMed  Google Scholar 

Pilsgaard F, Grynnerup AG-A, Løssl K, Bungum L, Pinborg A. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling. Acta Obstet Gynecol Scand. 2018;97(9):1105–1113.

Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. 2007;110(10):2222–9.

Article  CAS  PubMed  Google Scholar 

Oktem O, Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res. 2007;67(21):10159–62.

Article  CAS  PubMed  Google Scholar 

Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging (Albany NY). 2011;3(8):782–793.

Titus S, Szymanska KJ, Musul B, Turan V, Taylan E, Garcia- Milian R, Mehta S, Oktay K. Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation. Sci Rep. 2021;11(1):407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldfarb SB, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, Bang H, Patil S, Dickler MN, Oktay KH. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Res Treat. 2021;185(1):165–73.

Article  CAS  PubMed  Google Scholar 

Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, Dickler M, Robson M, Moy F, Goswami S, Oktay K. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013;5(172). https://doi.org/10.1126/scitranslmed.3004925.

Turan V, Oktay K. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging. Hum Reprod Update. 2020;26(1):43–57.

Article  CAS  PubMed  Google Scholar 

Oktay KH, Bedoschi G, Goldfarb SB, Taylan E, Titus S, Palomaki GE, Cigler T, Robson M, Dickler MN. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutat